טוען...
Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage
Hepatocellular adenoma/carcinoma (HCA/HCC) is a long-term complication of glycogen storage disease type-Ia (GSD-Ia) which is caused by a deficiency in glucose-6-phosphatase-α (G6Pase-α or G6PC), a key enzyme in gluconeogenesis. Currently, there is no therapy to address HCA/HCC in GSD-Ia. We have pre...
שמור ב:
| הוצא לאור ב: | J Inherit Metab Dis |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483852/ https://ncbi.nlm.nih.gov/pubmed/30637773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jimd.12056 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|